Salvage hematopoietic stem cell transplantation for patients with higher leukemia burden in relapsed or refractory acute myeloid leukemia: a ten-year study-Reference-Cited by-同舟云学术

Salvage hematopoietic stem cell transplantation for patients with higher leukemia burden in relapsed or refractory acute myeloid leukemia: a ten-year study

Published:2023-09-08 Issue:11 Volume:102 Page:3205-3216
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Jiang Shan,Lu Xuan,Wei Ruowen,Zhang Ao,Chen Haoran,Shi Wei,Xia Linghui^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00277-023-05406-z.pdf

Reference41 articles.

1. Löwenberg B, Downing JR, Burnett A (1999) Acute myeloid leukemia. N Engl J Med 341:1051–1062. https://doi.org/10.1056/NEJM199909303411407

2. Döhner H, Estey EH, Amadori S et al (2010) Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 115:453–474. https://doi.org/10.1182/blood-2009-07-235358

3. Othus M, Appelbaum FR, Petersdorf SH et al (2015) Fate of patients with newly diagnosed acute myeloid leukemia who fail primary induction therapy. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant 21:559–564. https://doi.org/10.1016/j.bbmt.2014.10.025

4. Estey E (2016) Why are there so few randomized trials for patients with primary refractory acute myeloid leukemia? Best Pract Res Clin Haematol 29:324–328. https://doi.org/10.1016/j.beha.2016.10.003

5. DeWolf S, Tallman MS (2020) How I treat relapsed or refractory AML. Blood 136:1023–1032. https://doi.org/10.1182/blood.2019001982

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Addition of ruxolitinib and decitabine to modified busulfan/cyclophosphamide conditioning regimen for prophylaxis relapse in high-risk acute myeloid leukemia: the phase 2 prospective study;Annals of Hematology;2024-09-07

2. Case report: Donor-derived CLL-1 chimeric antigen receptor T-cell therapy for relapsed/refractory acute myeloid leukemia bridging to allogeneic hematopoietic stem cell transplantation after remission;Frontiers in Immunology;2024-05-13

3. Long-term survival in a patient with primary refractory AML after salvage allogeneic hematopoietic transplantation and post-transplant localized irradiation and venetoclax maintenance: a case report;Frontiers in Oncology;2023-12-15